CA Patent

CA3008548C — Intravesical therapy for bladder cancer

Assigned to Photocure ASA · Expires 2025-09-23 · 1y expired

What this patent protects

This invention relates to an intravesical therapy for bladder cancer.

USPTO Abstract

This invention relates to an intravesical therapy for bladder cancer.

Drugs covered by this patent

hexaminolevulinate-hydrochloride (HEXAMINOLEVULINATE HYDROCHLORIDE)

Patent Metadata

Patent number: CA3008548C
Jurisdiction: CA
Classification: —
Expires: 2025-09-23
Drug substance claim: No
Drug product claim: No
Assignee: Photocure ASA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.